Medicine has developed throughout time but has remained forever concerned with the maintenance of health and thus the science of prevention and alleviation, and ultimately curing, of disease. To continue its development in new directions, medicine is now looking to nanomedicine, an emerging scientific specialty born from nanotechnology, which has grown up in the fields of engineering, physics, chemistry and biotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond.As our knowledge of the human body continues to improve, nanotechnology will be developed to monitor, repair and control human biological systems at the molecular level. This will offer unique opportunities for developing new therapeutic approaches to diagnose, prevent, treat and eradicate life-threatening diseases and conditions (such as cancer and diabetes), as well as resolving pain and improving medical techniques (such as bone repair and surgical techniques), through various novel nanotechnological approaches.Nanomedicine (ISSN 1743-5889) is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community.The nanomedicine field is still in its infancy, however, in the next few years there are likely to be further exciting developments across medical science, engineering, chemistry and physics. Diverse researchers working together under the nanomedicine umbrella will produce findings with potential medical uses: preventing, diagnosing and treating human diseases, as well as relieving pain. Nanomedicine will provide a critical overview of these advances as they unfold, helping to shape the future of medicine in this exciting era.
随着时间的推移,医学不断发展,但始终关注健康的维护,因此也关注预防和减轻疾病,并最终治愈疾病的科学。为了在新的方向上继续发展,医学现在正在寻找纳米医学,这是一个由纳米技术诞生的新兴科学专业,它在工程、物理、化学和生物技术领域中成长起来,现在正在向医学迈进,在未来十年及以后具有巨大的扩展和发展潜力。随着我们对人体知识的不断提高,纳米技术将被开发来监测、在分子水平上修复和控制人体生物系统。这将为开发新的治疗方法以诊断、预防、治疗和根除危及生命的疾病和病症提供独特的机会(如癌症和糖尿病),以及解决疼痛和提高医疗技术(如骨修复和外科手术技术)。纳米医学(ISSN 1743-5889)是一本独特的医学期刊,致力于解决医学纳米结构材料和设备、生物技术设备和分子机器系统以及纳米机器人方面的重大挑战和进展,以简洁、清晰和有吸引力的文章格式。该杂志是该领域所有参与者的宝贵信息来源-学术、工业和临床研究人员、制药和生物技术公司、监管机构和科学界的其他人。纳米医学领域仍处于起步阶段,但在未来几年内,医学、工程、化学和物理学领域可能会有进一步令人兴奋的发展。不同的研究人员在纳米医学的保护伞下共同努力,将产生具有潜在医学用途的发现:预防、诊断和治疗人类疾病,以及缓解疼痛。纳米医学将提供这些进展的关键概述,因为他们展开,帮助塑造未来的医学在这个令人兴奋的时代。
Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0120
Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0038
Liquid crystalline nanoreservoir releasing a highly skin-penetrating berberine oleate complex for psoriasis management.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0345
The effectiveness and safety of X-PDT for cutaneous squamous cell carcinoma and melanoma.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0094
Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0040
Nanoparticle-siRNA: a potential strategy for ovarian cancer therapy?
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0379
Nanoparticulate photosensitizer decorated with hyaluronic acid for photodynamic/photothermal cancer targeting therapy.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0204
Noninvasive biodegradable nanoparticles-in-nanofibers single-dose ocular insert: in vitro, ex vivo and in vivo evaluation.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0297
Gold nanoparticles for multimodal high-resolution imaging of transplanted cells for retinal replacement therapy.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0299
Nanosensors for therapeutic drug monitoring: implications for transplantation.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0150
Updates on the use of liposomes for active tumor targeting in cancer therapy.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0308
Development of near-infrared region luminescent N-acetyl-L-cysteine-coated Ag2S quantum dots with differential therapeutic effect.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0214
Potential anticancer activity and mechanism of action of nanoformulated curcumin in experimental Ehrlich ascites carcinoma-bearing animals.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0298
Oral delivery system for low molecular weight protamine-dextran-poly(lactic-co-glycolic acid) carrying exenatide to overcome the mucus barrier and improve intestinal targeting efficiency.
来源期刊:NanomedicineDOI:10.2217/NNM-2018-0322
Improved brain delivery of pueraria flavones via intranasal administration of borneol-modified solid lipid nanoparticles.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0417
Peptide-targeted liposomal delivery of dexamethasone for arthritis therapy.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0501
Paclitaxel-encapsulated core-shell nanoparticle of cetyl alcohol for active targeted delivery through oral route.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0419
Effects of silver nanoparticles functionalized with Cornus mas L. extract on architecture and apoptosis in rat testicle.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0193
Zn-doped CuO nanocomposites inhibit tumor growth by NF-κB pathway cross-linked autophagy and apoptosis.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0366
Biodistribution and biocompatibility of glycyrrhetinic acid and galactose-modified chitosan nanoparticles as a novel targeting vehicle for hepatocellular carcinoma.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0455
Biocompatibility in regenerative nanomedicine.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0140
Exosomal miR-196a-1 promotes gastric cancer cell invasion and metastasis by targeting SFRP1.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0053
Efficient and innocuous delivery of small interfering RNA to microglia using an amphiphilic dendrimer nanovector.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0176
EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses BRCA1-mutated breast cancer.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0132
Ligand decorated chitosan as an advanced nanocarrier for targeted delivery: a critical review.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0490
Programmed death-ligand 1 monoclonal antibody-linked immunoliposomes for synergistic efficacy of miR-130a and oxaliplatin in gastric cancers.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0073
Imaging in the repair of peripheral nerve injury.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0115
Inhibition of p38 MAPK in the brain through nasal administration of p38 inhibitor loaded in chitosan nanocapsules.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0496
The future application of nanomedicine and biomimicry in plastic and reconstructive surgery.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0119
Selenium nanoparticles induce autophagy mediated cell death in human keratinocytes.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0397
Silk fibroin-based nanotherapeutics: application in the treatment of colonic diseases.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0058
Direct effects of poly(ε-caprolactone) lipid-core nanocapsules on human immune cells.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0484
Immunoactive polysaccharide functionalized gold nanocomposites promote dendritic cell stimulation and antitumor effects.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0390
Lipid nanoparticles biocompatibility and cellular uptake in a 3D human lung model.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0256
Tumor blood perfusion-based requirement of nanoparticle dose-loadings for plasmonic photothermal therapy.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0494
Exploring an interesting dual functionality of anacardic acid for efficient paclitaxel delivery in breast cancer therapy.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0138
Opportunities and challenging issues of nanomaterials in otological fields: an occupational health perspective.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0114
Pharmaceutical design and development of perfluorocarbon nanocolloids for oxygen delivery in regenerative medicine.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0260
Mitochondria and nucleus delivery of active form of 10-hydroxycamptothecin with dual shell to precisely treat colorectal cancer.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0227
Physiological application of nanoparticles in calcium-related proteins and channels.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0004
Mesoporous gold nanoparticles for photothermal controlled anticancer drug delivery.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0242
Preparation and characterization of nano amitriptyline hydrochloride particles by spray freeze drying.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0116
Therapeutic potential of low-cost nanocarriers produced by green synthesis: macrophage uptake of superparamagnetic iron oxide nanoparticles.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0500
Garcinol-loaded novel cationic nanoliposomes: in vitro and in vivo study against B16F10 melanoma tumor model.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0022
Mechanistic insights into high permeation vesicle-mediated synergistic enhancement of transdermal drug permeation.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0519
Autodegradable clusters made from superparamagnetic nanoparticles with drug release properties.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0278
H2O2/near-infrared light-responsive nanotheronostics for MRI-guided synergistic chemo/photothermal cancer therapy.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0043
miRNA transfection via poly(amidoamine)-based delivery vector prevents hypoxia/reperfusion-induced cardiomyocyte apoptosis.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0363
Effects of nanoscale electric fields on the histology of liver cell dysplasia.
来源期刊:NanomedicineDOI:10.2217/nnm-2018-0260
Loading AKBA on surface of silver nanoparticles to improve their sedative-hypnotic and anti-inflammatory efficacies.
来源期刊:NanomedicineDOI:10.2217/nnm-2019-0211